Skip to main content

김재환 교수

Jaihwan Kim

서울대학교 내과 · 의학

연구실 소개

김재환 교수의 연구실은 주로 담도계 및 췌장암의 진단 및 치료 전략 개선을 목표로 하며, 특히 내 endoscopic 초음파를 활용한 조직 채취(에스-파이)와 ERCP 기반 진단의 정확도를 비교 분석하는 데 초점을 맞추고 있습니다. 또한 췌장암의 발병 기전을 규명하고자 Cdc6 단백질의 발현이 암 진행에 미치는 영향을 연구하며, 전임상적 및 임상 데이터 기반으로 FOLFIRINOX와 같은 표준 치료법의 유효성과 성별에 따른 반응 차이를 분석하고 있습니다. 특히 한국인 환자를 대상으로 한 임상 등록 데이터를 활용한 정밀의료 기반의 치료 전략 수립이 핵심 과제입니다.

췌장암내 endoscopic 진단FOLFIRINOXCdc6임상 등록 데이터

연구 현황

논문 수
200
총 인용 수
2,384
최근 5년 논문
50
주요 분야
의학

연구 성과 추이

표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.

5개년 연도별 논문 게재 수
50총합
2022
2023
2024
2025
2026
5개년 연도별 피인용 수
243총합
20222023202420252026

주요 논문

15
1
논문|인용수 69·2011
Clinical features of 20 patients with curatively resected biliary neuroendocrine tumours
Jaihwan Kim, Woo Jin Lee, Sang Hyub Lee, Kyoung Bun Lee, Ji Kon Ryu, Yong‐Tae Kim, Sun‐Whe Kim, Yong Bum Yoon, Jin‐Hyeok Hwang, Ho‐Seong Han, Sang Myung Woo, Sang‐Jae Park
SJR Q1Digestive and Liver Disease
EpidemiologyMedicine
2
논문|인용수 67·2016
Percutaneous transhepatic versus EUS-guided gallbladder drainage for malignant cystic duct obstruction
Jin Ho Choi, Hyoung Woo Kim, Jong-Chan Lee, Kyu-hyun Paik, Nak Jong Seong, Chang Jin Yoon, Jin‐Hyeok Hwang, Jaihwan Kim
SJR Q1Gastrointestinal Endoscopy
Pulmonary and Respiratory MedicineMedicine
3
논문|인용수 57·2018
Same‐session endoscopic ultrasound‐guided fine needle aspiration and endoscopic retrograde cholangiopancreatography‐based tissue sampling in suspected malignant biliary obstruction: A multicenter experience
Jung Hyun Jo, Chang Min Cho, Jae Hyuck Jun, Moon Jae Chung, Tae Hyeon Kim, Dong Wan Seo, Jaihwan Kim, Do Hyun Park
SJR Q1Journal of Gastroenterology and HepatologyOA

BACKGROUND AND AIM: Few studies compared endoscopic ultrasound (EUS)-guided fine needle aspiration (EUS-FNA) with endoscopic retrograde cholangiopancreatography (ERCP)-based tissue sampling in terms of diagnostic accuracy in suspected malignant biliary obstruction. We evaluated and compared the diagnostic performance of EUS-FNA and ERCP-based tissue sampling. METHODS: This multicenter study included 263 patients with suspected malignant biliary obstruction who underwent same-session EUS and ERCP

Pulmonary and Respiratory MedicineMedicine
4
논문|인용수 50·2019
Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome
Jaihwan Kim, Danielle Braun, Chinedu Ukaegbu, Tara G. Dhingra, Fay Kastrinos, Giovanni Parmigiani, Sapna Syngal, Matthew B. Yurgelun
SJR Q1Clinical Gastroenterology and HepatologyOA
Pathology and Forensic MedicineMedicine
5
논문|인용수 35·2012
Clinical outcomes of patients who experienced perforation associated with endoscopic retrograde cholangiopancreatography
Jaihwan Kim, Sang Hyub Lee, Woo Hyun Paik, Byeong Jun Song, Jin‐Hyeok Hwang, Ji Kon Ryu, Yong‐Tae Kim, Yong Bum Yoon
SJR Q1Surgical Endoscopy
Pulmonary and Respiratory MedicineMedicine
6
논문|인용수 34·2020
Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer
Jong-Chan Lee, Sang Myung Woo, Dong Woo Shin, Jinkook Kim, Se Yeol Yang, Min Jae Kim, Jin Won Kim, Ji‐Won Kim, Woo Jin Lee, Hyo Soung, Philiip Park, Jaihwan Kim
SJR Q3American Journal of Clinical Oncology

OBJECTIVE: By using the Korean Pancreatic Cancer (K-PaC) registry, we compared the clinical outcomes of FOLFIRINOX (FFX) and gemcitabine plus nab-paclitaxel (GNP) in patients with metastatic pancreatic cancer (MPC). METHODS: We constructed a web-based database of 3748 anonymized patients diagnosed with pancreatic ductal adenocarcinoma. MPC patients who received first-line FFX or GNP were enrolled. Overall survival (OS), progression-free survival, grade III to IV toxicity, and cross-over treatmen

OncologyMedicine
7
논문|인용수 28·2020
Cdc6 disruption leads to centrosome abnormalities and chromosome instability in pancreatic cancer cells
Yuna Youn, Jong-Chan Lee, Jaihwan Kim, Jae Kim, Jin‐Hyeok Hwang, Jae Kim, Jin‐Hyeok Hwang
SJR Q1Scientific ReportsOA

Abstract Cell division cycle 6 ( Cdc6 ) plays key roles in regulating DNA replication, and activation and maintenance of cell cycle check points. In addition, Cdc6 exerts oncogenic properties via genomic instability associated with incomplete DNA replication. This study aimed to examine the effects of Cdc6 on pancreatic cancer (PC) cells. Our results showed that Cdc6 expression was higher in clinical PC specimens (based on analysis of the GEPIA database) and cell lines, and the high Cdc6 express

Molecular BiologyBiochemistry, Genetics and Molecular Biology
8
논문|인용수 26·2016
Risk Factors for Gallstone Formation in Resected Gastric Cancer Patients
Kyu-hyun Paik, Jong-Chan Lee, Hyung Woo Kim, Jingu Kang, Yoon Suk Lee, Jin‐Hyeok Hwang, Sang Hoon Ahn, Do Joong Park, Hyung‐Ho Kim, Jaihwan Kim
SJR Q3MedicineOA

Previous studies reported increased incidence of gallstone formation after gastrectomy. However, there were few reports about factors other than surgical technique. The purpose of this study is to investigate the spectrum of risk factors of gallstone formation after gastrectomy. From June 2003 to December 2008, 1480 patients who underwent gastrectomy due to gastric cancer but had no gallstones before surgery were identified. Electronic medical records were retrospectively reviewed. Gallstones we

Pulmonary and Respiratory MedicineMedicine
9
논문|인용수 26·2011
Results of repeat endoscopic retrograde cholangiopancreatography after initial biliary cannulation failure following needle‐knife sphincterotomy
Jaihwan Kim, Ji Kon Ryu, Dong‐Won Ahn, Joo Kyung Park, Won Jae Yoon, Yong‐Tae Kim, Yong Bum Yoon
SJR Q1Journal of Gastroenterology and Hepatology

BACKGROUND AND AIM: After failed biliary cannulation with needle knife sphincterotomy (NKS), endoscopic retrograde cholangiopancreatography (ERCP) is sometimes repeatedly performed in clinically stable patients; however, there are few reports about the results. This study assessed the results of repeated ERCPs after failure with NKS. METHODS: After failed NKS, patients who underwent repeated ERCP for the same purpose within 3 days were retrospectively identified. Success was defined as deep plac

Pulmonary and Respiratory MedicineMedicine
10
논문|인용수 22·2010
Self-expandable metallic stent placement for malignant obstruction in patients with locally recurrent gastric cancer
Jaihwan Kim, Il Ju Choi, Chan Gyoo Kim, Jong Yeul Lee, Soo‐Jeong Cho, Sook Ryun Park, Jun Ho Lee, Keun Won Ryu, Young‐Woo Kim, Young-Iee Park
SJR Q1Surgical Endoscopy
SurgeryMedicine
11
논문|인용수 20·2016
Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes
Won Keun, Jung Wha Chung, Cho Jun-Hyeon, Joo Yeong Baeg, Eun Sun Jang, Hyuk Yoon, Jaihwan Kim, Jaihwan Kim, Cheol Min Shin, Young Soo Park, Jin‐Hyeok Hwang, Sook‐Hyang Jeong
SJR Q1PLoS ONEOA

Epidemiological data indicate that type 2 diabetes is associated with increased risk of hepatocellular carcinoma (HCC). However, risk stratification for HCC has not been fully elucidated in diabetic population. The aim of this study was to identify potential predictors of HCC in diabetic patients without chronic viral hepatitis. A cohort of 3,544 diabetic patients without chronic viral hepatitis or alcoholic cirrhosis was established and subjects were randomly allocated into a derivation and a v

EpidemiologyMedicine
12
논문|인용수 20·2015
Postoperative Carcinoembryonic Antigen as a Complementary Tumor Marker of Carbohydrate Antigen 19-9 in Pancreatic Ductal Adenocarcinoma
Jaihwan Kim, Yoon Suk Lee, In Kyeom Hwang, Bong Kyun Kang, Jai Young Cho, Yoo‐Seok Yoon, Ho‐Seong Han, Jin‐Hyeok Hwang
SJR Q2Journal of Korean Medical ScienceOA

The role of carcinoembryonic antigen (CEA) in pancreatic cancer remains poorly understood. Therefore, this study aimed to determine whether CEA is complementary to carbohydrate antigen 19-9 (CA19-9) in prognosis prediction after pancreatic cancer curative resection. We retrospectively reviewed records of 144 stage II curatively resected pancreatic cancer patients with preoperative and postoperative CEA and CA19-9 levels. Patients with normal preoperative CA19-9 were excluded. R0 resection margin

OncologyMedicine
13
논문|인용수 20·2021
Gender Differences in Patients with Metastatic Pancreatic Cancer Who Received FOLFIRINOX
Jinkook Kim, Jinkook Kim, Eunjeong Ji, Kwangrok Jung, In Ho Jung, Jaewoo Park, Jong-Chan Lee, Jin Won Kim, Jin Won Kim, Jin‐Hyeok Hwang, Jaihwan Kim, Jaihwan Kim
SJR Q2Journal of Personalized MedicineOA

Background: The combination of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) is a very effective chemotherapeutic regimen for unresectable pancreatic cancer. Previous studies have reported that female gender may be a predictor of a better response to FOLFIRINOX. This study was aimed at investigating the clinical outcomes and dose modification patterns of FOLFIRINOX by gender. Methods: Patients with metastatic pancreatic cancer (MPC) who began FOLFIRINOX as the first-line t

OncologyMedicine
14
리뷰|인용수 19·2015
Endoscopic Ultrasound-Guided Treatment of Pancreatic Cystic and Solid Masses
Jaihwan Kim
SJR Q2Clinical EndoscopyOA

Pancreatic tumor is one of the most difficult diseases to diagnose and treat because of its anatomical location and characteristics. Recently, there have been several innovative trials on the treatment of pancreatic tumors using endoscopic ultrasound (EUS) because it allows selective access to the difficult to reach target organ along the gastrointestinal tract and can differentiate vessels by color Doppler. Among these trials, several have investigated EUS-guided ethanol lavage with or without

OncologyMedicine
15
논문|인용수 18·2020
Gemcitabine Plus Cisplatin Chemotherapy Prolongs the Survival in Advanced Hilar Cholangiocarcinoma
Dong Woo Shin, Min Jae Kim, Jong-Chan Lee, Jaihwan Kim, Sang Myung Woo, Woo Jin Lee, Kwang Hyuck Lee, Jin‐Hyeok Hwang
SJR Q3American Journal of Clinical Oncology

OBJECTIVES: Gemcitabine plus cisplatin (GC) is recommended as first-line treatment for advanced cholangiocarcinoma. We investigated the impact of GC in patients with unresectable hilar cholangiocarcinoma (HC) based on the time taken for effective biliary drainage (EBD). MATERIALS AND METHODS: We retrospectively enrolled 113 patients with unresectable HC. Thirty-nine and 74 patients received GC chemotherapy and best supportive care (BSC), respectively. EBD was defined as a reduction in total bili

SurgeryMedicine

대표 연구 분야

OncologyPulmonary and Respiratory MedicineSurgeryEpidemiologyMolecular BiologyGastroenterology

김재환 교수의 연구를 Nubint에서 더 깊이 살펴보세요

이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.